Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
(Rac)-Antineoplaston A10
Cat. No.:
OB0225LY-0079
Appearance:
Solid
Purity:
≥98%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Add to basket
Product Overview
Description:
(Rac)-Antineoplaston A10 is a naturally occurring substance with anti-tumor properties.
Synonym:
Antineoplaston A10; 77658-84-5; 3-Phenylacetylamino-2,6-piperidinedione; N-(2,6-Dioxopiperidin-3-yl)-2-phenylacetamide; Benzeneacetamide,N-(2,6-dioxo-3-piperidinyl)-; N-(2,6-Dioxo-piperidin-3-yl)-2-phenyl-acetamide
CAS No.:
77658-84-5
Compound CID:
157096
Formula:
C13H14N2O3
Formula Weight:
246.26
Specification
Relative Density:
1.27 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
(Rac)-Antineoplaston A10 can be used to inhibit the growth of tumor cells.
Library Information
Targets:
GTPase superfamily
Receptors:
Ras
Pathways:
Apoptosis; MAPK; GPCR/G protein
Plate Number:
AOCL-2
Plate Location:
a2
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
27.5 mg/mL; 111.67 mM
